ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1164

Spectrum of Skin Eruption and Histological Findings in Adult-Onset Still’s Disease and Significance of Atypical Persistent Skin Eruptions

Elina Zuelgaray1, Maxime Battistella2, Camille Sallé de Chou1, Patrice Cacoub3, François Chasset4, Christopher Rein5, Nathan Peiffer-Smadja3, Fanny Domont3, Marie Chapalain6, Claude Bachmeyer4, Laurence Fardet6, Bruno Fautrel7, Martine Bagot1 and Jean-David Bouaziz1, 1Dermatology Department, Saint-Louis Hospital, Paris, France, 2Pathology Department, Saint-Louis Hospital, Paris, France, 3Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 4Dermatology Department, Tenon Hospital, Paris, France, 5Rheumatology Department, Hautepierre Hospital, Paris, France, 6Dermatology Department, Mondor Hospital, Paris, France, 7UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Adult-onset Still's disease

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Adult-onset Still disease (AOSD) is a rare systemic inflammatory disorder characterized by spiking fevers, polyarthritis and an evanescent salmon-pink maculopapular eruption. Several cases of atypical persistent skin eruption (APSE) have been reported in AOSD to date. APSE could be associated with AOSD poor prognosis and resistance to treatment. We report the second largest series of AOSD with accurate clinical and histological data.

Methods:

A multicenter retrospective study was conducted (6 french centers) including all patients with a diagnosis of AOSD (Yamaguchi and/or Fautrel criteria) with skin involvement and a skin biopsy between 2005 and 2017. Clinical, biological and histological data, delay of diagnosis and treatments used were recorded. A review of all APSE cases described in the literature was also performed.  

Results:

Thirty-six patients were included (median age: 46 years-old, female: 69%). Nineteen (53%) presented an APSE (Figure 1). Extracutaneous attempts included: arthralgia/arthritis (94%), lymphadenopathy (36%), hepato/splenomegaly (25%), pericarditis/pleurisy (11%). The following factors seemed to be increased in patients with APSE (n=19) in comparison with patients without APSE (n=17): time to diagnosis (p=0,1), arthritis (p=0.09), liver dysfunction (p=0,08), ferritin level higher than 1,500 ng/mL (p=0.018), number of line of treatments to achieve complete remission (p=0,08). Reactive hemophagocytic syndrome and associated malignancy were similar in both groups. Ninety-four cases of APSE in AOSD were previously reported, characterized by urticarial lesions (with a linear configuration in some cases), pigmented papules or plaques, lichenoid lesions or dermatomyositis-like lesions. Histology of APSE compared with evanescent salmon-pink maculopapular skin eruption displayed increased dermal inflammatory infiltrate and neutrophils, and increased epidermal alterations (dyskeratosis/necrotic keratinocytes, spongiosis).

Conclusion:

Cutaneous clinical and histological spectrum in AOSD is large and should not delay the diagnosis. These results have to be confirmed by large prospective cohorts.

Figure 1: A 58-year-old woman presenting a pruritic APSE (erythematous and pigmented papules and plaques of the cheeks and the leg) (A,B). Skin biopsy of the leg lesion revealed a moderate perivascular and interstitial dermal infiltrate composed of lymphocytes and neutrophils, a dermal oedema and vascular walls infiltrate (C)

 


Disclosure: E. Zuelgaray, None; M. Battistella, None; C. Sallé de Chou, None; P. Cacoub, None; F. Chasset, None; C. Rein, None; N. Peiffer-Smadja, None; F. Domont, None; M. Chapalain, None; C. Bachmeyer, None; L. Fardet, None; B. Fautrel, None; M. Bagot, None; J. D. Bouaziz, None.

To cite this abstract in AMA style:

Zuelgaray E, Battistella M, Sallé de Chou C, Cacoub P, Chasset F, Rein C, Peiffer-Smadja N, Domont F, Chapalain M, Bachmeyer C, Fardet L, Fautrel B, Bagot M, Bouaziz JD. Spectrum of Skin Eruption and Histological Findings in Adult-Onset Still’s Disease and Significance of Atypical Persistent Skin Eruptions [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/spectrum-of-skin-eruption-and-histological-findings-in-adult-onset-stills-disease-and-significance-of-atypical-persistent-skin-eruptions/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spectrum-of-skin-eruption-and-histological-findings-in-adult-onset-stills-disease-and-significance-of-atypical-persistent-skin-eruptions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology